Literature DB >> 6167173

Inhibition of Entamoeba histolytica cytotoxin by alpha 1 antiprotease and alpha 2 macroglobulin.

W B Lushbaugh, A B Kairalla, A F Hofbauer, P Arnaud, J R Cantey, F E Pittman.   

Abstract

We previously reported partial purification of a proteinaceous substance with cytotoxic and enterotoxic activity isolated from the soluble fraction of sonicated axenically cultivated Entamoeba histolytica trophozoites. Demonstration of cytotoxic activity of the preparation (amebal toxin) was dependent on removal of serum from the tissue culture assay system. The objective of the present study was to identify the factor(s) in non-immune sera responsible for producing in vitro inhibition of amebal toxin cytotoxicity on HeLa cells. Gel filtration of non-immune sera from adult humans or bovines demonstrated that two portions of the eluate had significant inhibitory against the toxin. A high molecular weight inhibitory fraction was identified as predominantly alpha-2 macroglobulin and a low molecular weight inhibitory fraction was identified as predominantly alpha-1 antiprotease. Preparative isoelectric focusing of human serum isolated inhibitory fractions containing these same alpha globulins. Alpha-2 macroglobulin was purified and alpha-1 antiprotease was partially purified from human serum by other methods and shown to have high inhibitory activity against the amebal cytotoxin. Substances that were inhibitory to the cytotoxic activity of the amebal toxin also mediated reattachment of toxin treated HeLa cells. We conclude that the characteristics of the serum inhibitors, especially their ability to reverse the cytotoxic effects of amebal toxin on HeLa cells, suggests that the amebal toxin has protease activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167173     DOI: 10.4269/ajtmh.1981.30.575

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

1.  Trypanosoma cruzi: killing and enhanced uptake by resident peritoneal macrophages treated with alpha-2-macroglobulin.

Authors:  T C Araújo-Jorge; M de N de Meirelles; L Isaac
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

Review 2.  Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.

Authors:  Ignacio Blanco; Beatriz Lara; Frederick de Serres
Journal:  Orphanet J Rare Dis       Date:  2011-04-12       Impact factor: 4.123

3.  Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNFalpha), and vascular endothelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgia.

Authors:  Ignacio Blanco; Sabina Janciauskiene; Izabela Nita; Enrique Fernández-Bustillo; Victoriano Cárcaba; César Gallo; Marlene Alvarez-Rico; Frederick de Serres; Nana Béridze
Journal:  Clin Rheumatol       Date:  2009-11-19       Impact factor: 2.980

4.  Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice.

Authors:  S L Stanley; T Zhang; D Rubin; E Li
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

5.  Use of indomethacin to demonstrate enterotoxic activity in extracts of Entamoeba histolytica trophozoites.

Authors:  I A Udezulu; G J Leitch; G B Bailey
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Isolation and differentiation of herpes simplex virus and Trichomonas vaginalis in cell culture.

Authors:  G A Gentry; N Lawrence; W Lushbaugh
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.